Search

everythinglearnresearchcommunity

for

Search:↓

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Calancardin B may help reduce inflammation in immune cells.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Canine dermal papilla cells and fibroblasts have distinct growth patterns and protein expressions.

Dermal adipose tissue in mice can change and revert to help with skin health.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Lower SMAD2/3 activation predicts more severe skin cancer.

Langerhans' cells are not responsible for depigmentation in this mouse model.

EPDS and MS might share an immune-related cause.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

αMSH may help regulate immune responses in hair follicles and its disruption could lead to hair loss.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

Adipose-derived stem cells help heal radiation skin damage by reducing cell death and inflammation.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

PRP injections for hair loss may cause scalp nodules that can persist but often regress on their own.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Thymic epithelial cells may be related to skin stem cells.